CO-DIRECTORS:
Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN
C. Kent Osborne, Baylor College of Medicine, Houston, TX
Peter M. Ravdin, UT Health Science Center San Antonio, San Antonio, TX
Charles A. Coltman, Jr., Ex-Officio, UT Health Science Center San Antonio, San Antonio, TX
For 34 years, the symposium’s mission has been to provide state-of-the-art information on breast cancer research. From a one-day regional conference the symposium has grown to a five-day program attended by a broad international audience of academic and private researchers and physicians from over 90 countries. The symposium aims to achieve a balance of clinical, translational and basic research, providing a forum for interaction, communication and education for a broad spectrum of researchers, health professionals and those with a special interest in breast cancer.
In 2007, the Cancer Therapy & Research Center (CTRC) at UT Health Science Center San Antonio and the American Association for Cancer Research announced a collaboration for the future of the San Antonio Breast Cancer Symposium (SABCS). The symposium has been renamed the CTRC-AACR San Antonio Breast Cancer Symposium. Complementing the clinical strengths of the highly regarded annual SABCS, the AACR's scientific prestige in basic, translational and clinical cancer research has created a unique and comprehensive scientific meeting that advances breast cancer research for the benefit of patients.
In 2005, Baylor College of Medicine became a joint sponsor of the symposium and remains in the CTRC-AACR collaboration. C. Kent Osborne, professor of medicine and molecular and cellular biology, director, Dan L. Duncan Cancer Center, director, Breast Center, Baylor College of Medicine; Peter M. Ravdin, director of the Breast Cancer Program, UT Health Science Center San Antonio and Carlos L. Arteaga, director, Breast Cancer Program Vanderbilt-Ingram Cancer Center, Vanderbilt University are co-directors of the symposium.